UA99513U - Method for treatment of transitory ischemic attack of lacunar genesis - Google Patents
Method for treatment of transitory ischemic attack of lacunar genesisInfo
- Publication number
- UA99513U UA99513U UAU201413629U UAU201413629U UA99513U UA 99513 U UA99513 U UA 99513U UA U201413629 U UAU201413629 U UA U201413629U UA U201413629 U UAU201413629 U UA U201413629U UA 99513 U UA99513 U UA 99513U
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- lacunar
- ischemic attack
- genesis
- dose
- Prior art date
Links
- 230000000302 ischemic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 229940035982 ceraxon Drugs 0.000 abstract 2
- YWAFNFGRBBBSPD-OCMLZEEQSA-M sodium;[[(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound [Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 YWAFNFGRBBBSPD-OCMLZEEQSA-M 0.000 abstract 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- BYPFEZZEUUWMEJ-UHFFFAOYSA-N Pentoxifylline Chemical compound O=C1N(CCCCC(=O)C)C(=O)N(C)C2=C1N(C)C=N2 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000032109 Transient ischaemic attack Diseases 0.000 abstract 1
- 230000000702 anti-platelet effect Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229960001476 pentoxifylline Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 201000010875 transient cerebral ischemia Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for treatment of transitory ischemic attack of lacunar genesis involves the use of antiplatelet, antihypertensive agents and statins. After determining the pathogenic lacunar subtype of transient ischemic attack, from the first day of treatment, Pentoxifylline at a dose of 5 ml and Ceraxon at the dose of 1000 mg per 200 ml of physiological sodium chloride solution is additionally administered by drip intravenous infusion 1 time per day for 5-7 days followed by intramuscular administration of Ceraxon at a daily dose of 500 mg for 7-10 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201413629U UA99513U (en) | 2014-12-19 | 2014-12-19 | Method for treatment of transitory ischemic attack of lacunar genesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201413629U UA99513U (en) | 2014-12-19 | 2014-12-19 | Method for treatment of transitory ischemic attack of lacunar genesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99513U true UA99513U (en) | 2015-06-10 |
Family
ID=53675537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201413629U UA99513U (en) | 2014-12-19 | 2014-12-19 | Method for treatment of transitory ischemic attack of lacunar genesis |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA99513U (en) |
-
2014
- 2014-12-19 UA UAU201413629U patent/UA99513U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ732507A (en) | Improved compositions for treating muscular dystrophy | |
| MY189601A (en) | Treatment of beta-thalassemia using actrii ligand traps | |
| MX395482B (en) | Antiproliferative compounds and methods of use thereof | |
| MY189466A (en) | Methods of modulating drug plasma levels using erythrohydroxybupropion | |
| EA201790726A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS | |
| ZA202102438B (en) | Melflufen dosage regimens for cancer | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| MY204827A (en) | Semaglutide in medical therapy | |
| MX2022007315A (en) | Sustained release olanzapine formulations. | |
| MX2022010782A (en) | Perfusion system. | |
| MX2019000413A (en) | Inhibitors of tryptophan 2,3-dioxygenase. | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| UA99513U (en) | Method for treatment of transitory ischemic attack of lacunar genesis | |
| RU2014106575A (en) | METHOD FOR PREVENTION OF BLEEDING WITH MYOMECTOMY | |
| UA104584U (en) | Method for the treatment of acute ischemic stroke | |
| UA98564U (en) | A method of treating transient ischemic attack atherothrombotic genesis | |
| UA105586U (en) | Method for treating hepatic encephalopathy | |
| SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
| EA201692531A1 (en) | METHODS OF TREATING INFECTIONS | |
| RU2014142874A (en) | A method of treating a hangover syndrome in persons not related to patients with alcoholism | |
| UA98493U (en) | A method of treating transient ischemic attack | |
| RU2013127881A (en) | APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| UA108523U (en) | METHOD OF TREATMENT OF PATIENTS WITH EARLY AGAINST POSTINCULAR Dementia | |
| UA98492U (en) | A method of treating transient ischemic attack cardioembolic genesis |